Solving the Challenge of Genome-Wide DNA Methylation Sequencing: Cost vs. Coverage

For years, DNA methylation researchers have faced a frustrating trade-off: pay for expensive whole-genome bisulfite sequencing (WGBS) to get full coverage, or use more affordable options like RRBS, arrays, or panels that limit discovery. On top of that, bisulfite conversion can damage DNA and add unnecessary complexity to your analysis.

But now, there's a better option!

Join us to learn about CUTANA™ meCUT&RUN, a smarter, more efficient approach to genome-wide DNA methylation profiling. This method avoids harsh bisulfite treatment while delivering high-resolution data across the genome. It’s cost-effective, gentle on samples, and requires low input—making it ideal for a wide range of applications.

If you're ready to move beyond the limitations of traditional methods, don’t miss this opportunity to see how meCUT&RUN can transform your research.

Speaker: Bryan Venters, PhD

As Senior Director of Genomic Technologies, Bryan Venters leads R&D programs at EpiCypher that seek to equip scientists with robust protocols for cutting-edge epigenomic mapping technologies (CUT&RUN/Tag, DNA methylation profiling, and Fiber-seq). Prior to joining EpiCypher in 2019, Bryan was a faculty member at Vanderbilt where his lab studied the epigenetic mechanisms underlying hormone signaling pathways.